Xiangjian Zhang Selected Research

Xiangjian Zhang Research Topics

Disease

37	Infarction (Infarctions) 07/2022 - 07/2009
37	Brain Ischemia (Cerebral Ischemia) 07/2022 - 07/2009
31	Ischemic Stroke 07/2022 - 04/2010
25	Stroke (Strokes) 07/2022 - 03/2010
21	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2021 - 08/2009
12	Inflammation (Inflammations) 06/2022 - 01/2012
12	Reperfusion Injury 01/2020 - 08/2009
12	Ischemia 05/2018 - 01/2009
7	Neoplasms (Cancer) 01/2022 - 10/2012
6	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 06/2012
5	Hypoxia (Hypoxemia) 01/2021 - 08/2014
5	Cerebral Infarction 01/2020 - 03/2015
5	Brain Edema (Cerebral Edema) 10/2019 - 12/2006
5	Edema (Dropsy) 01/2014 - 01/2011
4	Neuroinflammatory Diseases 11/2022 - 12/2019
3	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2017
3	Brain Injuries (Brain Injury) 09/2012 - 01/2009
2	Overweight 01/2022 - 09/2020
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2018
2	Hypoventilation 09/2020 - 01/2018
2	Obesity 09/2020 - 01/2018
2	Hypercapnia 09/2020 - 01/2018
2	Hypertension (High Blood Pressure) 02/2019 - 01/2019
2	Pancreatitis 04/2017 - 09/2012
2	Atherosclerosis 10/2015 - 01/2013
2	Rheumatoid Arthritis 06/2012 - 04/2012
1	Pre-Eclampsia (Preeclampsia) 06/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	COVID-19 10/2021
1	Disease Progression 10/2021
1	Pulmonary Embolism 06/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021

Drug/Important Bio-Agent (IBA)

14	Neuroprotective AgentsIBA 11/2021 - 05/2010
10	salicylhydroxamic acid (SHAM)IBA 11/2021 - 09/2012
9	Claudin-5IBA 08/2014 - 03/2010
8	Biological ProductsIBA 08/2014 - 04/2012
6	NF-kappa B (NF-kB)IBA 04/2017 - 01/2009
6	AntioxidantsIBA 04/2016 - 01/2011
5	CytokinesIBA 01/2022 - 12/2006
5	Pharmaceutical PreparationsIBA 11/2019 - 01/2013
5	Transcription Factors (Transcription Factor)IBA 01/2014 - 07/2009
4	Atorvastatin (Lipitor)FDA Link 01/2021 - 03/2010
4	oxymatrineIBA 01/2021 - 01/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019 - 12/2006
4	Therapeutic UsesIBA 10/2015 - 01/2013
3	Bromodeoxyuridine (BrdU)IBA 07/2022 - 10/2017
3	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2022 - 01/2018
3	Toll-Like Receptor 4IBA 06/2022 - 10/2015
3	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 09/2016
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2010
3	LipidsIBA 11/2019 - 12/2014
3	AcidsIBA 01/2019 - 10/2017
3	Saline SolutionIBA 05/2018 - 08/2014
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2017 - 05/2010
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2022 - 01/2018
2	Liraglutide FDA Link 07/2022 - 05/2018
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 04/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 03/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 01/2021
2	3-n-butylphthalide (butylphthalide)IBA 01/2021 - 10/2019
2	LeptinIBA 09/2020 - 01/2018
2	CateninsIBA 12/2019 - 10/2012
2	p38 Mitogen-Activated Protein KinasesIBA 11/2019 - 10/2010
2	Heme Oxygenase-1IBA 11/2019 - 06/2016
2	Small Interfering RNA (siRNA)IBA 01/2019 - 11/2017
2	oxidized low density lipoproteinIBA 09/2018 - 01/2016
2	nobiletinIBA 04/2016 - 07/2013
2	Polysorbates (PSML)FDA Link 04/2016 - 07/2013
2	Stem Cell FactorIBA 01/2015 - 01/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2015 - 01/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2014 - 03/2010
2	Carboxymethylcellulose Sodium (Polycell)FDA Link 01/2014 - 08/2013
2	bicyclolIBA 01/2014 - 08/2013
2	TNF Receptor-Associated Factor 6 (TRAF6)IBA 08/2013 - 07/2012
2	LuteolinIBA 09/2012 - 04/2012
2	tanshinoneIBA 05/2010 - 03/2010
2	HMGB1 Protein (HMG1)IBA 03/2010 - 03/2010
1	Thioctic Acid (Lipoic Acid)IBA 11/2022
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 07/2022
1	LipopolysaccharidesIBA 06/2022
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 06/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 06/2022
1	sodium bisulfide (NaHS)IBA 06/2022
1	Ferritins (Ferritin)IBA 01/2022
1	IronIBA 01/2022
1	fisogatinibIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	BilirubinIBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2022
1	AlbuminsIBA 01/2022
1	ArtesunateIBA 11/2021
1	Gefitinib (Iressa)FDA Link 06/2021
1	Dabigatran FDA Link 06/2021

Therapy/Procedure

11	Therapeutics 10/2021 - 01/2011
2	Intraperitoneal Injections 01/2020 - 11/2017